LSM1 over-expression in Saccharomyces cerevisiae depletes U6 snRNA levels

被引:23
作者
Luhtala, Natalie [2 ]
Parker, Roy [1 ,3 ]
机构
[1] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA
[2] Univ Arizona, Canc Biol Grad Interdisciplinary Program, Tucson, AZ 85721 USA
[3] Univ Arizona, Howard Hughes Med Inst, Tucson, AZ 85721 USA
基金
美国国家卫生研究院;
关键词
SM-LIKE PROTEINS; MESSENGER-RNA DEGRADATION; YEAST LA PROTEIN; PANCREATIC-CANCER; NUCLEAR-LOCALIZATION; GENE-EXPRESSION; BREAST-CANCER; COMPLEX; CASM; AMPLICON;
D O I
10.1093/nar/gkp572
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lsm1 is a component of the Lsm1-7 complex involved in cytoplasmic mRNA degradation. Lsm1 is over-expressed in multiple tumor types, including over 80% of pancreatic tumors, and increased levels of Lsm1 protein have been shown to induce carcinogenic effects. Therefore, understanding the perturbations in cell process due to increased Lsm1 protein may help to identify possible therapeutics targeting tumors over-expressing Lsm1. Herein, we show that LSM1 over-expression in the yeast Saccharomyces cerevisiae inhibits growth primarily due to U6 snRNA depletion, thereby altering pre-mRNA splicing. The decrease in U6 snRNA levels causes yeast strains over-expressing Lsm1 to be hypersensitive to loss of other proteins required for production or function of the U6 snRNA, supporting a model wherein excess Lsm1 reduces the availability of the Lsm2-7 proteins, which also assemble with Lsm8 to form a complex that binds and stabilizes the U6 snRNA. Yeast strains over-expressing Lsm1 also display minor alterations in mRNA decay and demonstrate increased susceptibility to mutations inhibiting cytoplasmic deadenylation, a process required for both 5'-to-3' and 3'-to-5' pathways of exonucleolytic decay. These results suggest that inhibition of splicing and/or deadenylation may be effective therapies for Lsm1-over-expressing tumors.
引用
收藏
页码:5529 / 5536
页数:8
相关论文
共 43 条
[11]   CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stability [J].
Fraser, MM ;
Watson, PM ;
Fraig, MM ;
Kelley, JR ;
Nelson, PS ;
Boylan, AM ;
Cole, DJ ;
Watson, DK .
CANCER RESEARCH, 2005, 65 (14) :6228-6236
[12]   A 1Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes [J].
Garcia, MJ ;
Pole, JCM ;
Chin, SF ;
Teschendorff, A ;
Naderi, A ;
Ozdag, H ;
Vias, M ;
Kranjac, T ;
Subkhankulova, T ;
Paish, C ;
Ellis, I ;
Brenton, JD ;
Edwards, PAW ;
Caldas, C .
ONCOGENE, 2005, 24 (33) :5235-5245
[13]   NEW YEAST-ESCHERICHIA-COLI SHUTTLE VECTORS CONSTRUCTED WITH INVITRO MUTAGENIZED YEAST GENES LACKING 6-BASE PAIR RESTRICTION SITES [J].
GIETZ, RD ;
SUGINO, A .
GENE, 1988, 74 (02) :527-534
[14]  
Hatfield L, 1996, MOL CELL BIOL, V16, P5830
[15]   Targeting the RNA splicing machinery as a novel treatment strategy for pancreatic carcinoma [J].
Hayes, GM ;
Carrigan, PE ;
Beck, AM ;
Miller, LJ .
CANCER RESEARCH, 2006, 66 (07) :3819-3827
[16]   The human LSm1-7 proteins colocalize with the mRNA-degrading enzymes Dcp1/2 and Xrn1 in distinct cytoplasmic foci [J].
Ingelfinger, D ;
Arndt-Jovin, DJ ;
Lührmann, R ;
Achsel, T .
RNA, 2002, 8 (12) :1489-1501
[17]   The cancer-associated Sm-like oncogene: A novel target for the gene therapy of pancreatic cancer [J].
Kelley, JR ;
Brown, JM ;
Frasier, MM ;
Baron, PL ;
Schweinfest, CW ;
Vournakis, JN ;
Watson, DK ;
Cole, DJ .
SURGERY, 2000, 128 (02) :353-360
[18]   Identification of Edc3p as an enhancer of mRNA decapping in Saccharomyces cerevisiae [J].
Kshirsagar, M ;
Parker, R .
GENETICS, 2004, 166 (02) :729-739
[19]   A protein that shuttles between the nucleus and the cytoplasm is an important mediator of RNA export [J].
Lee, MS ;
Henry, M ;
Silver, PA .
GENES & DEVELOPMENT, 1996, 10 (10) :1233-1246
[20]   Characterization of Sm-like proteins in yeast and their association with U6 snRNA [J].
Mayes, AE ;
Verdone, L ;
Legrain, P ;
Beggs, JD .
EMBO JOURNAL, 1999, 18 (15) :4321-4331